Post

A
Reposted

Polpharma S.A. (Starogard Gdański, Polska). 2024 revenue ~PLN3.5Mld. Largest Polish pharma. Cardiology, gastroenterology, CNS. Apo-Cardio, Polocard. API manufacturing. 7.5K employees.

The selectivity for para-substitution was >15:1 under optimized conditions.

8:52:06 PM · Jul 9, 2026
Sign in to reply and join the conversation.